This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Merck & Co., Inc.

Drug Names(s): MK-0429

Description: MK-0429 is an alpha-V beta-3 integrin antagonist. Small-molecule, avß3 antagonists with a basic nitrogen separated some distance from a carboxylic acid to mimic RGD, a alpha-5, 8 and V ligand. avß3 Integrin, a cell/matrix attachment protein, which recognizes the amino acid motif Arg-Gly-Asp (RGD).

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug